Bibliography
- Smits K , SmitsL, PeetersF et al.: Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.Int. Clin. Psychopharmacol.22(3), 137–143 (2007).
- Maron E , TammisteA, KallassaluK et al.: Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression.Eur. Neuropsychopharmacol.19(6), 451–456 (2009).
- Hu XZ , RushAJ, CharneyD et al.: Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.Arch. Gen. Psychiatry64(7), 783–792 (2007).
- Kronenberg S , ApterA, BrentD et al.: Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders.J. Child Adolesc. Psychopharmacol.17(6), 741–750 (2007).